Literature DB >> 26698229

Metabolic profile of naringenin in the stomach and colon using liquid chromatography/electrospray ionization linear ion trap quadrupole-Orbitrap-mass spectrometry (LC-ESI-LTQ-Orbitrap-MS) and LC-ESI-MS/MS.

Naiara Orrego-Lagarón1, Anna Vallverdú-Queralt2, Miriam Martínez-Huélamo3, Rosa M Lamuela-Raventos3, Elvira Escribano-Ferrer4.   

Abstract

Several biological activities (antioxidant, anti-inflammatory, anticarcinogenic) are attributed to naringenin (NAR)-a predominant flavonoid of citrus fruit and tomato-despite its low bioavailability after ingestion. NAR undergoes extensive metabolism when crossing the gastrointestinal tract, resulting in enteric, hepatic and microbial metabolites, some of them with recognized beneficial effects on human health. This study sought to provide new insights into the metabolism of NAR in regions of the gastrointestinal tract where it has been less studied: the stomach and colon. With this purpose, liquid chromatography coupled with an electrospray ionization hybrid linear ion trap quadrupole Orbitrap mass spectrometry technique (LC-ESI-LTQ-Orbitrap-MS) was used for an accurate identification of NAR metabolites, and liquid chromatography/electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) on a triple quadrupole was used for their identification and quantification. The combination of both analytical techniques provided a broader metabolic profile of NAR. As far as we know, this is the first in-depth metabolic profiling study of NAR in the stomach of mice. Three of the metabolites determined using the LC-LTQ-Orbitrap could not be identified by LC-ESI-MS/MS in stomach perfusion samples: apigenin, 3-(4-hydroxyphenyl) propionic acid and phloroglucinol. The number of colonic metabolites determined using the LTQ-Orbitrap-MS was more than twice the number identified by LC-ESI-MS/MS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intestinal perfusion; LC-ESI-LTQ-Orbitrap-MS; LC-ESI-MS/MS; Metabolism; Mice; Naringenin

Mesh:

Substances:

Year:  2015        PMID: 26698229     DOI: 10.1016/j.jpba.2015.10.040

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

Review 1.  Glucuronidated Flavonoids in Neurological Protection: Structural Analysis and Approaches for Chemical and Biological Synthesis.

Authors:  Maite Docampo; Adiji Olubu; Xiaoqiang Wang; Giulio Pasinetti; Richard A Dixon
Journal:  J Agric Food Chem       Date:  2017-08-21       Impact factor: 5.279

Review 2.  Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.

Authors:  Yang Yang; Myah Trevethan; Shu Wang; Ling Zhao
Journal:  J Nutr Biochem       Date:  2022-02-18       Impact factor: 6.117

3.  A Combined LC-MS Metabolomics- and 16S rRNA Sequencing Platform to Assess Interactions between Herbal Medicinal Products and Human Gut Bacteria in Vitro: a Pilot Study on Willow Bark Extract.

Authors:  Eva-Maria Pferschy-Wenzig; Kaisa Koskinen; Christine Moissl-Eichinger; Rudolf Bauer
Journal:  Front Pharmacol       Date:  2017-12-13       Impact factor: 5.810

4.  Fermentation Extract of Naringenin Increases the Expression of Estrogenic Receptor β and Modulates Genes Related to the p53 Signalling Pathway, miR-200c and miR-141 in Human Colon Cancer Cells Exposed to BPA.

Authors:  Sara Julietta Lozano-Herrera; Gabriel Luna-Bárcenas; Ramón Gerardo Guevara-González; Rocio Campos-Vega; Juan Carlos Solís-Sáinz; Ana Gabriela Hernández-Puga; Haydé Azeneth Vergara-Castañeda
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

5.  Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of Citrus × aurantium L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul Brantom; Andrew Chesson; Johannes Westendorf; Paola Manini; Fabiola Pizzo; Birgit Dusemund
Journal:  EFSA J       Date:  2021-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.